Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555562 · ClinicalTrials.gov registry record · NA
Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis
A NA study, sponsored by Surf Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT06555562 is a NA study that has completed, run by Surf Therapeutics. The registered enrollment target is 16 participants.
The verdict
NCT06555562, a NA study, has completed, sponsored by Surf Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is designed to investigate whether non-invasive ultrasound (US) that is optimized for stimulation and can elicit an anti-inflammatory response in people with Inflammatory Arthritis as compared to a sham intervention. The primary endpoint is the change in pro-inflammatory cytokines in blood drawn before and after US. Each participant receives 4 experimental US sessions, one of which is randomly assigned to be placebo.
Interventions
- DEVICE Ultrasound Stimulation
- DEVICE Non-active ultrasound stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-01-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06555562
The ClinicalTrials.gov registry entry for NCT06555562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Surf Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound Stimulation is the first listed.
NCT06555562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06555562 about?
NCT06555562 is a clinical study titled "Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis". This study is designed to investigate whether non-invasive ultrasound (US) that is optimized for stimulation and can elicit an anti-inflammatory response in people with Inflammatory Arthritis as compared to a sham intervention. The primary endpoint is the change in pro-inflammatory cytokines in bloo...
What is the current status of trial NCT06555562?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2025-10-01. Estimated completion is 2026-01-05.
What interventions are being tested in trial NCT06555562?
The interventions under investigation include: Ultrasound Stimulation (DEVICE), Non-active ultrasound stimulation (DEVICE).
Who is sponsoring clinical trial NCT06555562?
This trial is sponsored by Surf Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.